18F-Fluorodeoxyglucose Positron Emission Tomography: Useful Technique for Predicting Malignant Potential of Gastrointestinal Stromal Tumors

被引:0
作者
Yoichi Kamiyama
Ryuusuke Aihara
Toshihiro Nakabayashi
Erito Mochiki
Takayuki Asao
Hiroyuki Kuwano
Nobuo Oriuchi
Keigo Endo
机构
[1] Gunma University,Department of General Surgical Science (Surgery I)
[2] Graduate School of Medicine,Department of Diagnostic Radiology and Nuclear Medicine
[3] Gunma University,undefined
[4] Graduate School of Medicine,undefined
来源
World Journal of Surgery | 2005年 / 29卷
关键词
Positron Emission Tomography; Imatinib; Esophageal Squamous Cell Carcinoma; Standardize Uptake Value; Tumor Diameter;
D O I
暂无
中图分类号
学科分类号
摘要
The malignant potential of gastrointestinal stromal tumors (GISTs) is difficult to diagnose before surgery because the diagnoses are based on tumor diameter and mitotic index. The progression of small GISTs is always observed because they do not seem to have malignant potential. 18F-Fluorodeoxyglucose (FDG)-positron emission tomography (PET) is a useful technique for assessing tumor activity. The objective of this study was to determine if FDG-PET is useful for predicting the malignant potential of gastric GISTs. Ten patients diagnosed with gastric GISTs participated. FDG-PET was performed on all of them before tumor resection. A whole-body image was initiated 40 minutes after the injection of 275 to 370 MBq FDG. FDG uptake was assessed by a standardized uptake value. All tumors had FDG uptake. There was a significant correlation between the FDG uptake and both the Ki67 index and the mitotic index but not the tumor diameter. The FDG uptake and malignant potential of gastric GISTs had a significant correlation. FDG-PET may be of considerable value for predicting the malignant potential of gastric GISTs before surgery. A gastric GIST with a high FDG uptake should be regarded as having malignant potential.
引用
收藏
页码:1429 / 1435
页数:6
相关论文
共 66 条
[1]  
Miettinen M(1988)Gastrointestinal stromal tumors: an immunohistochemical study of cellular differentiation Am J Clin Pathol 89 601-610
[2]  
Hirota S(1998)Gain-of-function mutation of c-kit in human gastrointestinal stromal tumors Science 279 577-580
[3]  
Isozaki K(1998)Gastrointestinal pacemaker cell tumor (GI-PACT): gastrointestinal stromal tumors show phenotypic characteristics of the intestinal cells of Cajal Am J Pathol 152 1259-1269
[4]  
Moriyama Y(2000)Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival Ann Surg 231 51-58
[5]  
Kindblom LG(2001)Gastrointestinal stromal tumors: definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis Virchows Arch 438 1-12
[6]  
Remotti HE(2002)Clinical management of gastrointestinal stromal tumors: before and after STI-571 Hum Pathol 5 466-477
[7]  
Aldenborg F(2002)Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors N Engl J Med 347 472-80
[8]  
DeMatteo RP(2002)Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review Hum Pathol 35 478-483
[9]  
Lewis JJ(1995)Staging non-small cell lung cancer by whole-body positron emission tomographic imaging Ann Thorac Surg 60 1573-1581
[10]  
Leung D(1996)Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver Am J Surg 171 21-26